{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:26:47Z","timestamp":1781134007709,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370194"],"award-info":[{"award-number":["31370194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31570163"],"award-info":[{"award-number":["31570163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dongguan Bureau of Science and Technology"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.117","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:36:28Z","timestamp":1446683788000},"page":"6659-6665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neutralizing epitopes mapping of human adenovirus type 14 hexon"],"prefix":"10.1016","volume":"33","author":[{"given":"Qiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2015.10.117_bib0240","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1093\/cid\/cir043","article-title":"Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis","volume":"52","author":"Pavia","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.117_bib0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.117_bib0250","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3201\/eid1805.111584","article-title":"Novel human adenovirus strain, Bangladesh","volume":"18","author":"Matsushima","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.117_bib0255","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1167\/iovs.12-9656","article-title":"Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2015.10.117_bib0260","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygeno.2013.09.001","article-title":"Genomic analysis of HAdV-B14 isolate from the outbreak of febrile respiratory infection in China","volume":"102","author":"Mi","year":"2013","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.vaccine.2015.10.117_bib0265","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10096-011-1406-8","article-title":"Detection of three human adenovirus species in adults with acute respiratory infection in China","volume":"31","author":"Guo","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.117_bib0270","first-page":"119","article-title":"Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands","volume":"65","author":"Van Der Veen","year":"1957","journal-title":"Am J Hyg"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.117_bib0275","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3201\/1708.101760","article-title":"Deaths associated with human adenovirus-14p1 infections, Europe, 2009\u20132010","volume":"17","author":"Carr","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"5037","key":"10.1016\/j.vaccine.2015.10.117_bib0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.2.5037.131","article-title":"Pharyngo-conjunctival fever school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14","volume":"2","author":"Kendall","year":"1957","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2015.10.117_bib0285","first-page":"426","article-title":"An outbreak of acute respiratory infections among adults caused by adenovirus serotype 14","volume":"11","author":"Mevzos","year":"1966","journal-title":"Vopr Virusol"},{"issue":"10","key":"10.1016\/j.vaccine.2015.10.117_bib0290","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/522970","article-title":"Abrupt emergence of diverse species B adenoviruses at US military recruit training centers","volume":"196","author":"Metzgar","year":"2007","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2015.10.117_bib0295","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/598521","article-title":"A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14","volume":"199","author":"Lewis","year":"2009","journal-title":"J Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2015.10.117_bib0300","first-page":"1181","article-title":"Acute respiratory disease associated with adenovirus serotype 14 \u2013 four states, 2006\u20132007","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2015.10.117_bib0305","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/infdis\/jir040","article-title":"Pneumonia in military trainees: a comparison study based on adenovirus serotype 14 infection","volume":"203","author":"Vento","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.117_bib0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3201\/eid1803.111238","article-title":"Adenovirus-associated deaths in US military during postvaccination period, 1999\u20132010","volume":"18","author":"Potter","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.117_bib0315","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3201\/eid1605.091633","article-title":"Spread of adenovirus to geographically dispersed military installations, May\u2013October 2007","volume":"16","author":"Trei","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.117_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1086\/653083","article-title":"Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States","volume":"202","author":"Kajon","year":"2010","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.117_bib0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcv.2012.03.006","article-title":"A comparison of viral fitness and virulence between emergent adenovirus 14p1 and prototype adenovirus 14p strains","volume":"54","author":"Anderson","year":"2012","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.117_bib0330","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/525261","article-title":"Severe pneumonia due to adenovirus serotype 14: a new respiratory threat?","volume":"46","author":"Louie","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.117_bib0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1465-9921-11-116","article-title":"Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006\u20132007 epidemics in North America","volume":"11","author":"Houng","year":"2010","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.vaccine.2015.10.117_bib0340","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2015.10.117_bib0345","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/jmv.23325","article-title":"Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China","volume":"84","author":"Yu","year":"2012","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.117_bib0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","article-title":"Epitope mapping: the first step in developing epitope-based vaccines","volume":"21","author":"Gershoni","year":"2007","journal-title":"BioDrugs: Clin Immunother Biopharm Gene Ther"},{"issue":"23","key":"10.1016\/j.vaccine.2015.10.117_bib0355","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.117_bib0360","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00705-005-0722-7","article-title":"Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene","volume":"151","author":"Lu","year":"2006","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.10.117_bib0365","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2105-6-278","article-title":"Multiple sequence alignment accuracy and evolutionary distance estimation","volume":"6","author":"Rosenberg","year":"2005","journal-title":"BMC Bioinform"},{"issue":"4","key":"10.1016\/j.vaccine.2015.10.117_bib0370","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jcv.2010.01.005","article-title":"Human adenoviruses in respiratory infections: sequencing of the hexon hypervariable region reveals high sequence variability","volume":"47","author":"Biere","year":"2010","journal-title":"J Clin Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2015.10.117_bib0375","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.117_bib0380","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/mthe.1999.0001","article-title":"Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon","volume":"1","author":"Rux","year":"2000","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.117_bib0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmgm.2005.09.015","article-title":"Homology modelling and protein structure based functional analysis of five cucumovirus coat proteins","volume":"24","author":"Gellert","year":"2006","journal-title":"J Mol Graph Model"},{"issue":"37","key":"10.1016\/j.vaccine.2015.10.117_bib0390","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1016\/j.vaccine.2009.06.041","article-title":"Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein","volume":"27","author":"Yuan","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.10.117_bib0395","doi-asserted-by":"crossref","first-page":"e32938","DOI":"10.1371\/journal.pone.0032938","article-title":"Structure-based high-throughput epitope analysis of hexon proteins in B and C species human adenoviruses (HAdVs)","volume":"7","author":"Yuan","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.117_bib0400","doi-asserted-by":"crossref","first-page":"e11815","DOI":"10.1371\/journal.pone.0011815","article-title":"HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach","volume":"5","author":"Matthews","year":"2010","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.117_bib0405","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1371\/journal.pntd.0003089","article-title":"Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection","volume":"8","author":"Farrow","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.117_bib0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp100214b","article-title":"Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach","volume":"8","author":"Matthews","year":"2011","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.vaccine.2015.10.117_bib0415","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1172\/JCI39812","article-title":"Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice","volume":"120","author":"Shiratsuchi","year":"2010","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.vaccine.2015.10.117_bib0420","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2008.12.039","article-title":"Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2015.10.117_bib0425","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu","year":"2012","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.117_bib0430","doi-asserted-by":"crossref","first-page":"e41381","DOI":"10.1371\/journal.pone.0041381","article-title":"Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon","volume":"7","author":"Tian","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2015.10.117_bib0435","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JVI.00814-12","article-title":"Genome sequence of the first human adenovirus type 14 isolated in China","volume":"86","author":"Zhang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.117_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-0366-5_1","article-title":"Protein structure modeling with MODELLER","volume":"1137","author":"Webb","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"24","key":"10.1016\/j.vaccine.2015.10.117_bib0445","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","article-title":"Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon","volume":"76","author":"Wu","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.117_bib0450","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.10.117_bib0455","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JVI.02023-06","article-title":"Structure-based identification of a major neutralizing site in an adenovirus hexon","volume":"81","author":"Pichla-Gollon","year":"2007","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2015.10.117_bib0460","doi-asserted-by":"crossref","first-page":"12635","DOI":"10.1128\/JVI.79.20.12635-12642.2005","article-title":"Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications","volume":"79","author":"Ebner","year":"2005","journal-title":"J Virol"},{"issue":"40","key":"10.1016\/j.vaccine.2015.10.117_bib0465","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1016\/j.vaccine.2011.06.122","article-title":"Malaria vaccine candidate: design of a multivalent subunit alpha-helical coiled coil poly-epitope","volume":"29","author":"Olugbile","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.10.117_bib0470","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/CVI.00236-10","article-title":"Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine","volume":"18","author":"Shao","year":"2011","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501573X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501573X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T01:29:10Z","timestamp":1537234150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1501573X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":47,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X1501573X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.117","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing epitopes mapping of human adenovirus type 14 hexon","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}